Busulfan bulk supplier for pharma manufacturers

Busulfan Suppliers & Bulk Manufacturers

Available Forms: Injection (IV), Oral Tablet

Available Strengths: Injection: 6 mg/mL; Tablet: 2 mg

Reference Brands: US: Busulfex® (IV), Myleran® (oral); EU: Busilvex® (IV), Myleran® (tablet)

Busulfan is an oncology drug used in pre-transplant conditioning for CML and other cancers, available as 6 mg/mL IV vials and 2 mg tablets in the US and EU.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Busulfan, available in 6 mg/mL IV injection and 2 mg oral tablets, is a critical alkylating agent used in conditioning regimens prior to hematopoietic stem cell transplantation (HSCT). Approved in both the US and EU under brands like Busulfex® and Busilvex®, it plays a key role in treating chronic myelogenous leukemia (CML) and other hematologic cancers. Manufactured under strict GMP conditions, Busulfan is supplied in sterile, ready-to-infuse formulations, making it ideal for oncology-focused B2B partnerships, licensing, and supply in regulated markets. Reliable sourcing of Busulfan is essential for transplant protocols in cancer care facilities.

Busulfan — third party manufacturing & bulk supply

Busulfan is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Busulfan is supplied as Injection (IV), Oral Tablet — supplied in more than one dosage form, each with its own manufacturing economics, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Busulfan listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Busulfan →

Back to Listing

Frequently Asked Questions

Busulfan is listed as Injection (IV), Oral Tablet in Injection: 6 mg/mL; Tablet: 2 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Busulfan is referenced against US: Busulfex® (IV), Myleran® (oral); EU: Busilvex® (IV), Myleran® (tablet). Reference brands are shown for identification only and remain the property of their respective trademark owners.